Literature DB >> 12546332

Mycophenolate mofetil: new applications for this immunosuppressant.

Kevin G Moder1.   

Abstract

OBJECTIVES: This article should familiarize the reader with the pharmacokinetics, mechanisms of action, potential toxicities, and current and future applications of mycophenolate mofetil. DATA SOURCES: The current medical literature.
RESULTS: Mycophenolate mofetil is an immunosuppressive agent that has been used for transplant recipients. More recently, this agent has been used to treat several inflammatory conditions.
CONCLUSIONS: Mycophenolate mofetil has the potential to be a useful agent in the treatment of several inflammatory conditions, including systemic lupus erythematosus.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12546332     DOI: 10.1016/S1081-1206(10)63607-1

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  4 in total

Review 1.  Immunomodulatory approaches to the management of chronic urticaria: an immune-mediated inflammatory disease.

Authors:  Clifton O Bingham
Journal:  Curr Allergy Asthma Rep       Date:  2008-07       Impact factor: 4.806

2.  Mycophenolate mofetil (MMF) does not slow the progression of subclinical atherosclerosis in SLE over 2 years.

Authors:  Adnan N Kiani; Laurence S Magder; Michelle Petri
Journal:  Rheumatol Int       Date:  2011-07-27       Impact factor: 2.631

3.  Medical management of retroperitoneal fibrosis.

Authors:  Paul J Scheel; Stephen M Sozio; Nancy Feeley
Journal:  Trans Am Clin Climatol Assoc       Date:  2012

4.  Effect of mycophenolate mofetil on plasma bioelements in renal transplant recipients.

Authors:  Jolanta Kamińska; Joanna Sobiak; Joanna Maria Suliburska; Grażyna Duda; Maciej Głyda; Zbigniew Krejpcio; Maria Chrzanowska
Journal:  Biol Trace Elem Res       Date:  2011-08-26       Impact factor: 3.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.